B.R.D shared its experience in conducting stem cell trials in ALS patients in Israel at initiation of Brainstorm trial in the United States.

Dr. Neuman, CEO of BRD, was asked to attend the investigator’s meeting at Mass General Hospital in Boston, US to present the experience gained by BRD CRO from conducting 2 stem cell trials in ALS patients in Israel at the opening of the Brainstorm trial in the United States.